First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma—An Update on Patient Selection and Response Evaluation

Advanced hepatocellular carcinoma (HCC) with vascular invasion and/or extrahepatic spread and preserved liver function, according to stage C of the Barcelona Clinic Liver Cancer (BCLC) classification, has a dismal prognosis. The multi-targeted tyrosine-kinase receptor inhibitor (TKI) sorafenib is th...

Descripción completa

Detalles Bibliográficos
Autores principales: von Felden, Johann, Schulze, Kornelius, Gil-Ibanez, Ines, Werner, Tobias, Wege, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192519/
https://www.ncbi.nlm.nih.gov/pubmed/27916795
http://dx.doi.org/10.3390/diagnostics6040044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192519/
https://www.ncbi.nlm.nih.gov/pubmed/27916795
http://dx.doi.org/10.3390/diagnostics6040044

Ejemplares similares